These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27425618)

  • 1. Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.
    Sato S; Tang YJ; Wei Q; Hirata M; Weng A; Han I; Okawa A; Takeda S; Whetstone H; Nadesan P; Kirsch DG; Wunder JS; Alman BA
    Cell Rep; 2016 Jul; 16(4):917-927. PubMed ID: 27425618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
    Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
    J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
    Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
    J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional roles of CSPG4/NG2 in chondrosarcoma.
    Jamil NS; Azfer A; Worrell H; Salter DM
    Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas.
    Mellai M; Annovazzi L; Bisogno I; Corona C; Crociara P; Iulini B; Cassoni P; Casalone C; Boldorini R; Schiffer D
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
    Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
    Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells.
    Cattaruzza S; Ozerdem U; Denzel M; Ranscht B; Bulian P; Cavallaro U; Zanocco D; Colombatti A; Stallcup WB; Perris R
    Angiogenesis; 2013 Apr; 16(2):309-27. PubMed ID: 23124902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
    You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
    Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease?
    Kirton JP; Crofts NJ; George SJ; Brennan K; Canfield AE
    Circ Res; 2007 Sep; 101(6):581-9. PubMed ID: 17673669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin signaling increases in proliferating NG2+ progenitors and astrocytes during post-traumatic gliogenesis in the adult brain.
    White BD; Nathe RJ; Maris DO; Nguyen NK; Goodson JM; Moon RT; Horner PJ
    Stem Cells; 2010 Feb; 28(2):297-307. PubMed ID: 19960516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spatially and temporally restricted mouse model of soft tissue sarcoma.
    Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
    Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG2 expression in NG2 glia is regulated by binding of SoxE and bHLH transcription factors to a Cspg4 intronic enhancer.
    Gotoh H; Wood WM; Patel KD; Factor DC; Boshans LL; Nomura T; Tesar PJ; Ono K; Nishiyama A
    Glia; 2018 Dec; 66(12):2684-2699. PubMed ID: 30306660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells.
    Chen C; Zhao M; Tian A; Zhang X; Yao Z; Ma X
    Oncotarget; 2015 Jul; 6(19):17570-83. PubMed ID: 25999350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NG2/CSPG4 and progranulin in the posttraumatic glial scar.
    Schäfer MKE; Tegeder I
    Matrix Biol; 2018 Aug; 68-69():571-588. PubMed ID: 29054751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ninjurin 1 mediates peripheral nerve regeneration through Schwann cell maturation of NG2-positive cells.
    Tomita Y; Horiuchi K; Kano K; Tatsukawa T; Matsuo R; Hayasaka T; Yoshida Y; Kabara M; Yasuda S; Nakajima K; Nakagawa N; Takehara N; Okizaki A; Hasebe N; Kawabe JI
    Biochem Biophys Res Commun; 2019 Nov; 519(3):462-468. PubMed ID: 31526566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.
    Poon R; Hong H; Wei X; Pan J; Alman BA
    PLoS One; 2012; 7(5):e37940. PubMed ID: 22666417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.